Soo Chin Lee
National University Hospital, Singapore · National University Hospital Singapore, Singapore · Consultant
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
32
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
41 more share only the name and are not shown
Trial papers in breast cancer
33
PubMed author-name match
Trials
Studies that name Soo Chin Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:45 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07725328 · Pragmatic Mobile Health Trial to Promote Cancer Screening and Healthy BehaviorsNational University Hospital, Singapore · enrolling by invitation · Cancer Screening, Chronic Diseases in Older Adults, Early Cancer Detection · principal investigator
- Ph1/Ph2NCT07681297 · Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System DiseaseNational University Hospital, Singapore · not yet recruiting · Advanced Solid Tumor Cancer, Triple-Negative Breast Cancer (TNBC), CNS Disease · principal investigator
- N/ANCT07283107 · Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean WomenNational University Hospital, Singapore · enrolling by invitation · This Study Evaluates Interventions to Increase Surveillance Mammography Uptake for Early Breast Cancer Detection Among Singaporean Women · principal investigator
- Ph1/Ph2NCT06027983 · Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid TumorsNational University Hospital, Singapore · not yet recruiting · HER2+ Advanced Breast Cancer, Other Solid Tumors · principal investigator
- Ph1/Ph2NCT05491083 · Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast CancerNational University Hospital, Singapore · recruiting · Advanced Solid Tumor, Triple Negative Breast Cancer · principal investigator
- Ph1/Ph2NCT05275777 · A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast CancerNational University Hospital, Singapore · active not recruiting · HER2-negative Breast Cancer, Advanced Solid Tumor · principal investigator
- Ph2NCT05181033 · Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 InhibitorNational University Hospital, Singapore · recruiting · Breast Cancer · principal investigator
- Ph1/Ph2NCT05035745 · Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)National University Hospital, Singapore · recruiting · Advanced Refractory Solid Tumors, Advanced Triple Negative Breast Cancers, Metastatic Triple Negative Breast Cancers · principal investigator
- N/ANCT04279509 · Selecting Chemotherapy With High-throughput Drug Screen Assay Using Patient Derived Organoids in Patients With Refractory Solid Tumours (SCORE)National University Hospital, Singapore · unknown · Organoids, HNSCC, Epithelial Ovarian Cancer · principal investigator
- Ph1/Ph2NCT04280536 · Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)National University Hospital, Singapore · active not recruiting · Breast Cancer · principal investigator
- Ph2NCT03168074 · Phase II Study of Single Agent LenvatinibNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- Ph2NCT03114722 · Citrate 4% Versus Heparinised Saline in Preventing Peripherally Inserted Central Catheter (PICC) OcclusionsNational University Hospital, Singapore · unknown · Occlusion · principal investigator
- N/ANCT02811406 · The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related AscitesNational University Hospital, Singapore · unknown · Ascites, Hypotension · principal investigator
- Ph2NCT02790580 · Dose-dense Doxorubicin/Cyclophosphamide With Intermittent Low-dose Sunitinib in Breast Cancer PatientsNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- Ph1/Ph2NCT02562118 · Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast CancerNational University Hospital, Singapore · active not recruiting · Breast Cancer · principal investigator
- Ph1/Ph2NCT02396108 · Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast CancerNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- N/ANCT02083224 · Familial Cancer Registry and DNA BankNational University Hospital, Singapore · unknown · Cancer · principal investigator
- N/ANCT02078388 · Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer PatientsNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- Ph1/Ph2NCT02030561 · NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric CancerNational University Hospital, Singapore · unknown · Breast Cancer, Gastric Cancer · principal investigator
- Ph2NCT01803503 · Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid TumorsNational University Hospital, Singapore · unknown · Solid Tumors, Breast Cancer, Non-small Cell Lung Cancer · principal investigator
- Ph2NCT01309607 · Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast CancerNational University Hospital, Singapore · unknown · ErbB2-Positive Stage I-III Breast Cancer · principal investigator
- N/ANCT01247480 · Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast CancerNational University Hospital, Singapore · unknown · Breast Tumor · principal investigator
- N/ANCT01247467 · Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Breast Tumor - a Pilot StudyNational University Hospital, Singapore · unknown · Breast Tumor · principal investigator
- Ph2NCT01176799 · Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast TumorNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- N/ANCT00941200 · Pharmacogenetic DNA BankNational University Hospital, Singapore · unknown · Cancer · principal investigator
- N/ANCT00941408 · Biomarker Study of Breast TumorsNational University Hospital, Singapore · unknown · Breast Tumors · principal investigator
- Ph2NCT00807950 · Phase II Study of Simvastatin in Primary Breast Cancer; Test of Its Potential Selectivity on Basal Subtype Breast CancerNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- Ph2NCT00669773 · Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer PatientNational University Hospital, Singapore · unknown · Breast Cancer · principal investigator
- Ph1/Ph2NCT00416130 · Clinical Trial of SAHA in Patients With Breast CancerNational University Hospital, Singapore · unknown · Breast Cancer · study chair
- Ph2NCT00212069 · Serum Proteomics to Predict Gemcitabine Sensitivity in Breast CancerNational University Hospital, Singapore · completed · Metastatic Breast Cancer · principal investigator
- Ph2NCT00212082 · Gene Expression Profiles in Predicting Chemotherapy Response in Breast CancerNational University Hospital, Singapore · completed · Metastatic Breast Cancer · principal investigator
- Ph2NCT00212095 · Docetaxel Combined With Ketoconazole in Treatment of Breast CancerNational University Hospital, Singapore · completed · Metastatic Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 41 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:45 UTC. The ranking covers the 200 most relevant of 33 PubMed records, and a shared surname and initials can bring in a namesake. All 33 on PubMed
- 252 citationsRCR 7.5
- 240 citationsRCR 7.0
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.Breast Cancer Res Treat · 2010169 citationsRCR 3.8
- 89 citationsRCR 2.6
- Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients.Breast Cancer Res Treat · 201468 citationsRCR 2.0
- Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.Clin Cancer Res · 202061 citationsRCR 2.2
- PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients.Pharmacogenomics J · 200855 citationsRCR 1.5
- 36 citationsRCR 1.1
- Chemotherapy-induced tumor gene expression changes in human breast cancers.Pharmacogenet Genomics · 200935 citationsRCR 0.7
- Impact of UDP-gluconoryltransferase 2B17 genotype on vorinostat metabolism and clinical outcomes in Asian women with breast cancer.Pharmacogenet Genomics · 201133 citationsRCR 0.9